[go: up one dir, main page]

DK1368016T3 - Parenterale indgivelsesformer indeholdende en suspension af saltet af tramadol og diclofenac - Google Patents

Parenterale indgivelsesformer indeholdende en suspension af saltet af tramadol og diclofenac

Info

Publication number
DK1368016T3
DK1368016T3 DK01994735T DK01994735T DK1368016T3 DK 1368016 T3 DK1368016 T3 DK 1368016T3 DK 01994735 T DK01994735 T DK 01994735T DK 01994735 T DK01994735 T DK 01994735T DK 1368016 T3 DK1368016 T3 DK 1368016T3
Authority
DK
Denmark
Prior art keywords
diclofenac
suspension
salt
tramadol
parenteral administration
Prior art date
Application number
DK01994735T
Other languages
English (en)
Inventor
Johannes Bartholomaeus
Heinrich Kugelmann
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Application granted granted Critical
Publication of DK1368016T3 publication Critical patent/DK1368016T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK01994735T 2000-11-28 2001-11-27 Parenterale indgivelsesformer indeholdende en suspension af saltet af tramadol og diclofenac DK1368016T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10059020A DE10059020A1 (de) 2000-11-28 2000-11-28 Parenteral applizierbare Darreichungsformen

Publications (1)

Publication Number Publication Date
DK1368016T3 true DK1368016T3 (da) 2006-07-31

Family

ID=7664956

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01994735T DK1368016T3 (da) 2000-11-28 2001-11-27 Parenterale indgivelsesformer indeholdende en suspension af saltet af tramadol og diclofenac

Country Status (12)

Country Link
US (1) US6875447B2 (da)
EP (1) EP1368016B1 (da)
JP (1) JP4188084B2 (da)
CN (1) CN100384410C (da)
AT (1) ATE323477T1 (da)
AU (1) AU2002224896A1 (da)
CY (1) CY1105625T1 (da)
DE (2) DE10059020A1 (da)
DK (1) DK1368016T3 (da)
ES (1) ES2262703T3 (da)
PT (1) PT1368016E (da)
WO (1) WO2002043723A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110201121A1 (en) * 2005-08-24 2011-08-18 Berggren Oy Ab Method of testing a liquid sample, a test unit, and an automatized system of a plurality of test units
EP2128123A4 (en) * 2007-01-29 2011-04-20 Medrx Co Ltd NON-STEROIDAL ANTI-INFLAMMATORY SALT AND ORGANIC AMINO COMPOUND AND USE THEREOF
JP5307835B2 (ja) * 2008-01-14 2013-10-02 バイオキット,エス.アー. 流体中に粒子を分散させる装置およびその方法
AU2013204763B2 (en) * 2008-01-14 2015-06-04 Biokit, S.A. Device for distributing particles in a fluid and methods therefor
EP2281558A1 (en) * 2009-08-06 2011-02-09 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical compounds of O-Desmethyl-Tramadol and COX-inhibitors
EP2593096A4 (en) * 2010-07-12 2014-02-26 Yung Shin Pharm Ind Co Ltd DICLOFENAC SALT OF TRAMADOL
WO2012142273A1 (en) 2011-04-12 2012-10-18 Revogenex Inc. Intravenous administration of tramadol
US9980900B2 (en) 2015-12-22 2018-05-29 Revogenex Ireland Ltd Intravenous administration of tramadol
US9693949B1 (en) 2015-12-22 2017-07-04 Revogenex Ireland Ltd Intravenous administration of tramadol
US10022321B2 (en) 2016-06-30 2018-07-17 Revogenex Ireland Ltd. Intravenous administration of tramadol

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016273A (en) * 1975-07-16 1977-04-05 American Cyanamid Company Sustained release forms of certain oxazepines for parenteral administration
DE3324193A1 (de) * 1983-07-05 1985-01-17 Troponwerke Gmbh & Co Kg Depot-antiphlogistika
US5283067A (en) * 1987-01-30 1994-02-01 Ciba-Geigy Corporation Parenteral suspensions
ATE169498T1 (de) * 1991-09-06 1998-08-15 Mcneilab Inc Zusammensetzung, die eine tramadol-verbindung und acetaminophen enthält, und ihre verwendung
AU661723B2 (en) * 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
CA2143044C (en) * 1994-02-21 2005-04-12 Yasutaka Igari Matrix for sustained-release preparation
PT704206E (pt) * 1994-09-30 2003-01-31 Mika Pharma G Fur Die E Und V Composicao farmaceutica
AU7472798A (en) * 1997-05-07 1998-11-27 Algos Pharmaceutical Corporation Cox-2 inhibitors in combination with nmda-blockers for treating pain
DE19732928C2 (de) * 1997-07-31 2000-05-18 Gruenenthal Gmbh Verwendung substituierter Imidazolidin-2,4-dion-Verbindungen als Schmerzmittel
WO2000029022A1 (en) * 1998-11-12 2000-05-25 Algos Pharmaceutical Corporation Cox-2 inhibitors in combination with centrally acting analgesics
CA2351224A1 (en) * 1998-11-12 2000-05-25 Algos Pharmaceutical Corporation Cox-2 inhibitors in combination with nmda-blockers for treating pain
JP4722295B2 (ja) * 1999-05-27 2011-07-13 エイカスフィアー・インコーポレーテッド 多孔性薬剤マトリクスおよびその製造方法

Also Published As

Publication number Publication date
DE10059020A1 (de) 2002-05-29
JP4188084B2 (ja) 2008-11-26
US6875447B2 (en) 2005-04-05
ES2262703T3 (es) 2006-12-01
US20030203037A1 (en) 2003-10-30
JP2004514692A (ja) 2004-05-20
HK1060971A1 (en) 2004-09-03
ATE323477T1 (de) 2006-05-15
WO2002043723A1 (de) 2002-06-06
AU2002224896A1 (en) 2002-06-11
EP1368016B1 (de) 2006-04-19
CN100384410C (zh) 2008-04-30
CY1105625T1 (el) 2010-12-22
PT1368016E (pt) 2006-08-31
DE50109572D1 (de) 2006-05-24
CN1477955A (zh) 2004-02-25
EP1368016A1 (de) 2003-12-10

Similar Documents

Publication Publication Date Title
IS6957A (is) Tatrat sölt af 5,8,14,-tríasatetrasýkló[10.3.1.02,11.04,9]-hexadeka-2(11),3,5,7,9,-pentaen og lyfjafræðilegar samsetningar af þeim
DK1487493T3 (da) Konjugater af cytotoksiske midler og biologisk aktive peptider
NO20043702L (no) 8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel
NO20030627D0 (no) Hydrogel-drevet medikament doseringsform
ATE514418T1 (de) Rasch zerfallende feste darreichungsformen mit nichtbröseliger konsistenz und pullulan
PT1207867E (pt) Formas de administracao farmaceuticas orais retardadas contendo tramadol
DK1178958T3 (da) N-cyanomethylamider som proteaseinhibitorer
DK1498411T3 (da) Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel
DE60333294D1 (de) Kontrollierte verabreichung von arzneien
IS2457B (is) Samsetningar af lyfjum (t.d. klórprómasíni og pentamídíni) fyrir meðhöndlun á æxlistruflunum
DK1296671T3 (da) Gabapentinanaloger til sövnforstyrrelser
DK1372624T3 (da) Lægemiddel på basis af tramadol
DK1557415T3 (da) Heterocykliske forbindelser og antitumorlægemidler indeholdende samme som den aktive ingrediens
MA27115A1 (fr) Sel de perindopril et les compositions pharmaceutiques qui les contiennent
DK1280799T3 (da) Orthosubstituerede anthranilsyreamider og anvendelse heraf som lægemidler
DE50301661D1 (de) Darreichungsform von Ibuprofen-Natrium
DK1368016T3 (da) Parenterale indgivelsesformer indeholdende en suspension af saltet af tramadol og diclofenac
ATE432068T1 (de) Cetirizin und pseudoephedrin enthaltende tablette
DK1781277T3 (da) Kombinationssammensætning, der omfatter Ibuprofen og Paracetamol
ID27771A (id) Turunan triazol-piridazin tersubstitusi, komposisi farmasi yang dibuat dari bahan itu
DE60225686D1 (de) Paracetamol enthaltende tablette
HRP20031057B1 (hr) Tableta koja sadrži cetirizin i pseudoefedrin
BRPI0417265A (pt) composição farmacêutica compreendendo um princìpio ativo e sulfobetaìna
DK1161239T3 (da) 3- cyclopropylmethoxy-4-difluormethoxy-N-(3,5-dichlorpyrid-4-yl)benzamid til behandling af dissemineret sklerose
EP1399467A4 (en) PRODRUGS ACTIVATED BY PEPTIDDEFORMYLASE